Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Short term Debt (2022 - 2025)

Historic Short term Debt for Exagen (XGN) over the last 4 years, with Q3 2025 value amounting to $680000.0.

  • Exagen's Short term Debt rose 5813.95% to $680000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $680000.0, marking a year-over-year increase of 5813.95%. This contributed to the annual value of $423000.0 for FY2024, which is 6022.73% up from last year.
  • Latest data reveals that Exagen reported Short term Debt of $680000.0 as of Q3 2025, which was up 5813.95% from $667000.0 recorded in Q2 2025.
  • Exagen's Short term Debt's 5-year high stood at $2.5 million during Q1 2025, with a 5-year trough of $190000.0 in Q4 2022.
  • For the 4-year period, Exagen's Short term Debt averaged around $554333.3, with its median value being $345500.0 (2024).
  • In the last 5 years, Exagen's Short term Debt soared by 551.18% in 2024 and then soared by 84589.55% in 2025.
  • Exagen's Short term Debt (Quarter) stood at $190000.0 in 2022, then skyrocketed by 38.95% to $264000.0 in 2023, then soared by 60.23% to $423000.0 in 2024, then skyrocketed by 60.76% to $680000.0 in 2025.
  • Its Short term Debt stands at $680000.0 for Q3 2025, versus $667000.0 for Q2 2025 and $2.5 million for Q1 2025.